 |
PDBsum entry 3qti
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3qti
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
A drug resistance screen using a selective met inhibitor reveals a spectrum of mutations that partially overlap with activating mutations found in cancer patients.
|
|
|
Authors
|
|
R.Tiedt,
E.Degenkolbe,
P.Furet,
B.A.Appleton,
S.Wagner,
J.Schoepfer,
E.Buck,
D.A.Ruddy,
J.E.Monahan,
M.D.Jones,
J.Blank,
D.Haasen,
P.Drueckes,
M.Wartmann,
C.Mccarthy,
W.R.Sellers,
F.Hofmann.
|
|
|
Ref.
|
|
Cancer Res, 2011,
71,
5255-5264.
[DOI no: ]
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
